Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

Clinical trial NCT00578227 · COMPLETED

Trial details

NCT number: NCT00578227
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Papillomavirus

Start date: 2007-12-15
Primary completion: 2008-12-01
Enrollment: 814

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.